CM Life Sciences II Inc. does not have significant operations. It intends to effect a merger, capital stock exchange, asset acquisition, stock purchase, reorganization, or similar business combination with one or more businesses in the life sciences sector. The company was incorporated in 2020 and is based in New York, New York.
IPO Year: 2026
Exchange: NASDAQ
| Date | Price Target | Rating | Analyst |
|---|
10-K - Columbus Circle Capital Corp II (0002088805) (Filer)
8-K - Columbus Circle Capital Corp II (0002088805) (Filer)
8-K - Columbus Circle Capital Corp II (0002088805) (Filer)
8-K - Columbus Circle Capital Corp II (0002088805) (Filer)
424B4 - Columbus Circle Capital Corp II (0002088805) (Filer)
424B4 - Columbus Circle Capital Corp II (0002088805) (Filer)
CERT - Columbus Circle Capital Corp II (0002088805) (Filer)
8-A12B - Columbus Circle Capital Corp II (0002088805) (Filer)
EFFECT - Columbus Circle Capital Corp II (0002088805) (Filer)
424B3 - SomaLogic, Inc. (0001837412) (Filer)
Insider purchases reveal critical bullish sentiment about the company from key stakeholders. See them live in this feed.
4 - Columbus Circle Capital Corp II (0002088805) (Issuer)
Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.
4 - Columbus Circle Capital Corp II (0002088805) (Issuer)
3 - Columbus Circle Capital Corp II (0002088805) (Issuer)
3 - Columbus Circle Capital Corp II (0002088805) (Issuer)
3 - Columbus Circle Capital Corp II (0002088805) (Issuer)
3 - Columbus Circle Capital Corp II (0002088805) (Issuer)
3 - Columbus Circle Capital Corp II (0002088805) (Issuer)
3 - Columbus Circle Capital Corp II (0002088805) (Issuer)
3 - Columbus Circle Capital Corp II (0002088805) (Issuer)
3 - Columbus Circle Capital Corp II (0002088805) (Issuer)
4 - SomaLogic, Inc. (0001837412) (Issuer)
This live feed shows all institutional transactions in real time.
SC 13G - SomaLogic, Inc. (0001837412) (Subject)
SC 13G/A - SomaLogic, Inc. (0001837412) (Subject)
SC 13D - SomaLogic, Inc. (0001837412) (Subject)
SC 13G - CM Life Sciences II Inc. (0001837412) (Subject)